This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hendershot, E. Articles by Sung, L. Search for Related Content PubMed PubMed Citation Articles by Hendershot, E. Articles by Sung, L. Social Bookmarking                   What's this?

Tumor Necrosis in Pediatric Osteosarcoma: Impact of Modern Therapies

Hospital for Sick Children in Toronto, Ontario, Canada, eleanor.hendershot{at}sickkids.ca

Alberto Pappo, MD

Division of Hematology/Oncology at the Hospital for Sick Children

David Malkin, MD

Division of Hematology/Oncology at the Hospital for Sick Children

Lillian Sung, MD

Division of Hematology/Oncology at the Hospital for Sick Children in Toronto, Ontario

Tumor necrosis following preoperative chemotherapy in patients with osteosarcoma is a predictor of overall survival. With modern therapies, 45% of patients are expected to achieve more than 90% tumor necrosis. Investigators at the authors’ center, however, increasingly noted that patients were experiencing inferior necrosis responses. A retrospective study of treated patients at the center was undertaken to examine this. The purpose of this study was to determine (1) whether the number of patients with favorable histological responses had changed over time and (2) whether the percentage of patients with favorable responses was similar to published outcomes. Chart reviews were performed on patients treated from 1993 to 2003 according to the Pediatric Oncology Group 9351, regimen A protocol. Twenty-one patients met all eligibility requirements; 52% of patients had more than 90% necrosis. No correlation existed between degree of necrosis and year of treatment (r = 0.06; P = .8). Patients with osteosarcoma treated at the authors’ institution have comparable tumor necrosis responses to published outcomes, and no change occurred over time. This study stresses the importance of rigorous retrospective reviews before implementing treatment changes.

Key Words: osteosarcoma • tumor necrosis • prognostic factors • chemotherapy • survival

Journal of Pediatric Oncology Nursing, Vol. 23, No. 4, 176-181 (2006)
DOI: 10.1177/1043454206289786


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?